Trial Profile
Phase 2 Study of SK-1011 - Subfoveal choroidal neovascularization secondary to age-related macular degeneration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs SK 1011 (Primary)
- Indications Age-related macular degeneration; Choroidal neovascularisation
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanwa Kagaku Kenkyusho
- 08 Dec 2015 New trial record